Abou Al Saud, 2016 - Google Patents
Investigation of phenotypic rescue of Mybpc3 deficient mouseAbou Al Saud, 2016
View PDF- Document ID
- 10969953040265774345
- Author
- Abou Al Saud S
- Publication year
External Links
Snippet
Mutations in the myosin binding protein C gene (MYBPC3) are a frequent cause of hypertrophic cardiomyopathy (HCM) and calcineurin plays a major role in hypertrophic remodelling. However, a functional link between MYBPC3 mutations and calcineurin has not …
- 101150034357 MYBPC3 gene 0 title abstract description 140
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sanbe et al. | Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2 | |
| Wijnker et al. | Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue | |
| Deng et al. | Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy | |
| CN114423496B (en) | KLF-induced cardiomyogenesis | |
| Goeman et al. | Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals | |
| Sun et al. | Distinct roles of smooth muscle and non-muscle myosin light chain-mediated smooth muscle contraction | |
| Dentice et al. | The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the dio 2 genes to Nkx-2.5 and GATA-4 transcription factors | |
| WO2010010887A1 (en) | Tissue expression promoter | |
| Chua et al. | Mechanical stretch inhibits microRNA499 via p53 to regulate calcineurin-a expression in rat cardiomyocytes | |
| Mi-Mi et al. | In vivo elongation of thin filaments results in heart failure | |
| Oh et al. | Role of the PRC2-Six1-miR-25 signaling axis in heart failure | |
| Ross et al. | Lem2 is essential for cardiac development by maintaining nuclear integrity | |
| Greer-Short et al. | AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models | |
| WO2005018673A1 (en) | Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby | |
| Keller et al. | Bcl-x short-isoform is essential for maintaining homeostasis of multiple tissues | |
| Roslan et al. | Slack K+ channels confer protection against myocardial ischaemia/reperfusion injury | |
| Yoo et al. | Enhancing atrial‐specific gene expression using a calsequestrin cis‐regulatory module 4 with a sarcolipin promoter | |
| Elnakish et al. | Cardiac remodeling caused by transgenic overexpression of a corn Rac gene | |
| Pan et al. | Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis | |
| Zhang et al. | Syncoilin is required for generating maximum isometric stress in skeletal muscle but dispensable for muscle cytoarchitecture | |
| Hwang et al. | Exocytosis proteins: typical and atypical mechanisms of action in skeletal muscle | |
| Abou Al Saud | Investigation of phenotypic rescue of Mybpc3 deficient mouse | |
| JP2013006783A (en) | Gene for load sensitivity | |
| Heineke | Screening for novel calcium-binding proteins that regulate cardiac hypertrophy: CIB1 as an example | |
| JP4476754B2 (en) | Hair regeneration method |